首页> 外文期刊>Epidemiology and Infection >Prevalence of mumps antibodies in the Israeli population in relation to mumps vaccination policy and incidence of disease
【24h】

Prevalence of mumps antibodies in the Israeli population in relation to mumps vaccination policy and incidence of disease

机译:以色列人群中流行性腮腺炎抗体与流行性腮腺炎疫苗接种政策和疾病发生率的关系

获取原文
获取原文并翻译 | 示例
           

摘要

We examined the prevalence of mumps antibodies in the Israeli population in relation to mumps vaccination policy and past and subsequent incidence of disease. The levels of specific IgG antibodies against mumps were tested in 3330 residual sera collected during 1997-1998 from an age-stratified population sample. Against the background of a consistent MMR vaccination coverage of >90%, the age- and sex-adjusted seropositivity to mumps was 77.0%. No significant differences between genders were found. Seropositivity in the 10-13 years age group, born just before the introduction of the MMR vaccine, was the lowest (59 %). These birth cohorts were the target of an outbreak of mumps in 2005 that occurred among high-school students and military recruits. A trend of waning immunity was observed between the first and second vaccine doses. The seroepidemiological data demonstrate that immunity levels below the herd immunity threshold, along with social mixing and crowded conditions facilitated the occurrence of mumps outbreaks. Periodical serosurveys are an essential component in the evaluation of the vaccination policy against mumps.
机译:我们检查了流行性腮腺炎抗体在以色列人群中的流行程度,与流行性腮腺炎疫苗接种政策以及过去和以后的疾病发病率有关。在1997-1998年期间从年龄分层的人群样本中收集的3330个残留血清中测试了针对腮腺炎的特异性IgG抗体的水平。在MMR疫苗接种率始终> 90%的背景下,经年龄和性别调整后的腮腺炎血清阳性率为77.0%。没有发现性别之间的显着差异。在刚接种MMR疫苗之前出生的10-13岁年龄组的血清阳性率最低(59%)。这些出生人群是2005年高流行学生中流行性腮腺炎的目标。在第一和第二疫苗剂量之间观察到免疫力减弱的趋势。血清流行病学数据表明,低于人群免疫阈值的免疫水平,以及社会交往和拥挤状况促进了腮腺炎暴发的发生。定期的血清调查是评估腮腺炎疫苗政策的重要组成部分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号